Bloomberg Law
Free Newsletter Sign Up
Bloomberg Law
Welcome
Go
Free Newsletter Sign Up

Insulin, Epinephrine Discount Rule Clears White House Review

Dec. 18, 2020, 3:21 PM

A rule tying health center federal grant money to patient discounts for insulin and epinephrine could be published at any time after the White House concluded its review Thursday.

Sign-off by the Office of Management and Budget is the final step before the rule is published in the Federal Register. The final rule is a result of President Donald Trump’s July executive order on access to affordable life-saving medicines.

The order requires federally-qualified health centers to pass any discounts they get on insulin or injectable epinephrine drugs directly on to patients or forgo federal funding. Those health centers buy the ...